Literature DB >> 9611774

The role of glycosyl-phosphatidylinositol in signal transduction.

D R Jones1, I Varela-Nieto.   

Abstract

Glycosyl-phosphatidylinositol (GPI) lipids have a structural role as protein anchors to the cell surface. In addition, they are implicated in hormone, growth factor and cytokine signal transduction. Their phosphodiesteric hydrolysis mediated by an activated phospholipase results in the generation of water soluble oligosaccharide species termed the inositol phosphoglycan (IPG). This product has been demonstrated to possess biological properties when added exogenously to cells mimicking the biological effects of a variety of extracellular ligands. This may be accomplished since IPG is generic for a family of closely related species which are released in a tissue-specific manner and additionally have cell-specific targets. Micro-organic synthesis has recently been able to shed new light on this topic by the introduction of defined oligosaccharide analogues of IPG for the assessment of their biological activity. These have complemented the findings observed with purified IPG from biological sources thus strengthening the belief that the GPI/IPG signalling system represents a truly novel aspect of transmembrane signalling.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9611774     DOI: 10.1016/s1357-2725(97)00144-1

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  11 in total

Review 1.  Diabetes and the role of inositol-containing lipids in insulin signaling.

Authors:  D R Jones; I Varela-Nieto
Journal:  Mol Med       Date:  1999-08       Impact factor: 6.354

2.  Cross talk of pp125(FAK) and pp59(Lyn) non-receptor tyrosine kinases to insulin-mimetic signaling in adipocytes.

Authors:  G Müller; S Wied; W Frick
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

3.  A chemical approach to unraveling the biological function of the glycosylphosphatidylinositol anchor.

Authors:  Margot G Paulick; Martin B Forstner; Jay T Groves; Carolyn R Bertozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-12       Impact factor: 11.205

4.  Significance of glycosylphosphatidylinositol-anchored protein enrichment in lipid rafts for the control of autoimmunity.

Authors:  Yetao Wang; Yoshiko Murakami; Teruhito Yasui; Shigeharu Wakana; Hitoshi Kikutani; Taroh Kinoshita; Yusuke Maeda
Journal:  J Biol Chem       Date:  2013-07-17       Impact factor: 5.157

5.  Relationships between urinary inositol excretions and whole-body glucose tolerance and skeletal muscle insulin receptor phosphorylation.

Authors:  April J Stull; John P Thyfault; Mark D Haub; Richard E Ostlund; Wayne W Campbell
Journal:  Metabolism       Date:  2008-11       Impact factor: 8.694

6.  Genetic modification of Bacillus subtilis for production of D-chiro-inositol, an investigational drug candidate for treatment of type 2 diabetes and polycystic ovary syndrome.

Authors:  Ken-ichi Yoshida; Masanori Yamaguchi; Tetsuro Morinaga; Maya Ikeuchi; Masaki Kinehara; Hitoshi Ashida
Journal:  Appl Environ Microbiol       Date:  2006-02       Impact factor: 4.792

7.  ACTH stimulates the release of alkaline phosphatase through Gi-mediated activation of a phospholipase C and the release of inositol-phosphoglycan.

Authors:  Claudia N Martini; Silvia G Vaena de Avalos; María del Carmen Vila
Journal:  Mol Cell Biochem       Date:  2004-03       Impact factor: 3.396

8.  Plasma membrane microdomains act as concentration platforms to facilitate intoxication by aerolysin.

Authors:  L Abrami; F G van Der Goot
Journal:  J Cell Biol       Date:  1999-10-04       Impact factor: 10.539

Review 9.  The glycosylphosphatidylinositol anchor: a complex membrane-anchoring structure for proteins.

Authors:  Margot G Paulick; Carolyn R Bertozzi
Journal:  Biochemistry       Date:  2008-06-17       Impact factor: 3.162

10.  Insulin-mimicking bioactivities of acylated inositol glycans in several mouse models of diabetes with or without obesity.

Authors:  Susumu Suzuki; Chitose Suzuki; Yoshinori Hinokio; Yasushi Ishigaki; Hideki Katagiri; Makoto Kanzaki; Viatcheslav N Azev; Nilanjana Chakraborty; Marc d'Alarcao
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.